Cannabinoids can effectively target different subtypes of breast cancer and display several properties that aid in minimizing the early onset of drug resistance, such as dose reduction, improved uptake across the cell membrane, and curtailing drug efflux through ATP-binding cassette transporters. Here, ABCA4 is linked to breast cancer.